Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Castelain

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Pathologie-Biologie|January 1, 1997
[Research of type 1, 2 and 3 hepatitis C virus specific antibodies in relation to the viral genotype in chronically infected patients]S Castelain, G Duverlie, H Khorsi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 5, 2018
BK polyomavirus in the urine for follow-up of kidney transplant recipientsE Brochot, V Descamps, L Handala, et al.
Journal of Medical Virology|December 21, 2006
Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadineS Castelain, D Bonte, F Penin, et al.
Journal of Viral Hepatitis|August 4, 2017
Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virusC Fournier, T W Hoffmann, V Morel, et al.
Journal of Virology|May 24, 2000
Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesisC François, G Duverlie, D Rebouillat, et al.
Journal of Hepatology|July 1, 1997
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patientsH Khorsi, S Castelain, A Wyseur, et al.
Journal of Clinical Microbiology|December 14, 2011
Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patientsV Descamps, A Op de Beeck, C Plassart, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 11, 2018
Multicenter performance evaluation of the Unyvero IAI cartridge for detection of intra-abdominal infectionsH Ciesielczuk, M Wilks, S Castelain, et al.
Journal of Viral Hepatitis|May 22, 2009
A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective studyP Deltenre, V Canva, M El Nady, et al.
The Journal of Nutrition, Health & Aging|January 24, 2022
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care FacilitiesJ Moyet, F Helle, G Bourdenet, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pathologie-Biologie|January 1, 1997
[Research of type 1, 2 and 3 hepatitis C virus specific antibodies in relation to the viral genotype in chronically infected patients]S Castelain, G Duverlie, H Khorsi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 5, 2018
BK polyomavirus in the urine for follow-up of kidney transplant recipientsE Brochot, V Descamps, L Handala, et al.
Journal of Medical Virology|December 21, 2006
Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadineS Castelain, D Bonte, F Penin, et al.
Journal of Viral Hepatitis|August 4, 2017
Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virusC Fournier, T W Hoffmann, V Morel, et al.
Journal of Virology|May 24, 2000
Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesisC François, G Duverlie, D Rebouillat, et al.
Journal of Hepatology|July 1, 1997
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patientsH Khorsi, S Castelain, A Wyseur, et al.
Journal of Clinical Microbiology|December 14, 2011
Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patientsV Descamps, A Op de Beeck, C Plassart, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 11, 2018
Multicenter performance evaluation of the Unyvero IAI cartridge for detection of intra-abdominal infectionsH Ciesielczuk, M Wilks, S Castelain, et al.
Journal of Viral Hepatitis|May 22, 2009
A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective studyP Deltenre, V Canva, M El Nady, et al.
The Journal of Nutrition, Health & Aging|January 24, 2022
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care FacilitiesJ Moyet, F Helle, G Bourdenet, et al.
Pageof 4